The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities
Open accessAbstract
A mouse model for Down syndrome, Ts1Cje, has been developed. This model has made possible a step in the genetic dissection of the learning, behavioral, and neurological abnormalities associated with segmental trisomy for the region of mouse chromosome 16 homologous with the so-called “Down syndrome region” of human chromosome segment 21q22. Tests of learning in the Morris water maze and assessment of spontaneous locomotor activity reveal distinct learning and behavioral abnormalities, some of which are indicative of hippocampal dysfunction. The triplicated region in Ts1Cje, from Sod1 to Mx1 , is smaller than that in Ts65Dn, another segmental trisomy 16 mouse, and the learning deficits in Ts1Cje are less severe than those in Ts65Dn. In addition, degeneration of basal forebrain cholinergic neurons, which was observed in Ts65Dn, was absent in Ts1Cje.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These same populations of basal forebrain neurons typically develop less severe atrophy in the Ts1Cje (Sago et al., 1998) and Ts65Dn-App ϩ/ϩ/Ϫ mice (our unpublished observation) or older ages compared with that occurring in age-matched Ts65Dn mice.”
From App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome (2003) · cites this paper as Sago et al., 1998
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two segmental trisomy mouse models of DS, Ts65Dn (Davisson et al., 1990), and Ts1Cje (Sago et al., 1998) mice, survive to adulthood and exhibit a number of the morphological, biochemical, and transcriptional changes seen in the human disease (Davisson et al., 1990;Reeves et al., 1995;Holtzman et al., 1996).”
From App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome (2003) · cites this paper as Sago et al., 1998
The cited source says what the claim attributes to it.
In the citing paper
“These mice do not develop BFCN atrophy and degeneration, and they have less severe learning and behavioral deficits than Ts65Dn mice (Sago et al., 1998).”
From App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome (2003) · cites this paper as Sago et al., 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
Telenius, H., Carter, N. P., Bebb, C., Nordenskjöld, M., Ponder, B. A. J., & Tunnacliffe, A. (1992) · Genomics · doi:10.1016/0888-7543(92)90147-k · Cited by 1,422
A mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913
Nasir, J., Floresco, S., OʼKusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A. H., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 878
Amyloid β-Protein and the Genetics of Alzheimer's Disease
Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18295 · Cited by 805
Down syndrome phenotypes: the consequences of chromosomal imbalance.
Korenberg, J. R., Chen, X. N., Schipper, R. D., Sun, Z., Gonsky, R., Gerwehr, S., Carpenter, N. J., Däumer, C., Dignan, P. S. J., & Distèche, C. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4997 · Cited by 784
Pittler, S. J., & Baehr, W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8322 · Cited by 562
Staeheli, P., Haller, O., Boll, W., Lindenmann, J.-M., & Weissmann, C. (1986) · Cell · doi:10.1016/0092-8674(86)90493-9 · Cited by 488
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448
Self-citation
Research works printed but not linked: 1
- M T Davisson, C Schmidt, R H Reeves, N G Irving, E C Akeson, B S Harris, R T Bronson Prog Clin Biol Res 384, 117–133 (1993).
Cited by
Sorted by citations
Items 101–200 of 381
Postnatal lethality and cardiac anomalies in the Ts65Dn Down Syndrome mouse model
Moore, C. S. (2006) · Mammalian Genome · doi:10.1007/s00335-006-0032-8 · Cited by 76
Erb, C., Troost, J., Kopf, S. R., Schmitt, U., Löffelholz, K., Soreq, H., & Klein, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00287.x · Cited by 71
Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues
Belichenko, P. V., Kleschevnikov, A. M., Becker, A., Wagner, G. E., Lysenko, L. V., Yu, Y. E., & Mobley, W. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134861 · Cited by 73
Self-citationUsing mouse models to explore genotype–phenotype relationship in Down syndrome
Salehi, A., Faizi, M., Belichenko, P. V., & Mobley, W. C. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20164 · Cited by 70
Self-citationLi, H., Cherry, S. M., Klinedinst, D. K., DeLeon, V. B., Redig, J. K., Reshey, B., Chin, M. T., Sherman, S. L., Maslen, C. L., & Reeves, R. H. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.960872 · Cited by 73
The sequence of human chromosome 21 and implications for research into Down syndrome.
Gardiner, K., & Davisson, M. L. (2000) · Genome biology · doi:10.1186/gb-2000-1-2-reviews0002 · Cited by 69
The proteins of human chromosome 21
Gardiner, K., & Costa, A. C. S. (2006) · American Journal of Medical Genetics. Part C, Seminars in Medical Genetics · doi:10.1002/ajmg.c.30098 · Cited by 74
DSCAM Contributes to Dendrite Arborization and Spine Formation in the Developing Cerebral Cortex
Maynard, K. R., & Stein, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2811-12.2012 · Cited by 67
Increased lipid peroxidation in Down’s syndrome mouse models
Ishihara, K., Amano, K., Takaki, E., Ebrahim, A. S., Shimohata, A., Shibazaki, N., Inoue, I., Takaki, M., Ueda, Y., Sago, H., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06294.x · Cited by 67
Self-citationMouse Models of Cognitive Disorders in Trisomy 21: A Review
Sérégaza, Z., Roubertoux, P. L., Jamon, M., & Soumireu-Mourat, B. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9056-9 · Cited by 69
New approaches to studying early brain development in Down syndrome
Baburamani, A. A., Patkee, P. A., Arichi, T., & Rutherford, M. A. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14260 · Cited by 74
Ling, K., Hewitt, C., Tan, K.-L., Cheah, P.-S., Vidyadaran, S., Lai, M. I., Lee, H.-C., Simpson, K., Hyde, L., Pritchard, M. A., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-624 · Cited by 68
Contestabile, A., Fila, T., Bartesaghi, R., & Ciani, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00168.x · Cited by 64
Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of down Syndrome.
Goodliffe, J. W., Olmos-Serrano, J. L., Aziz, N. M., Pennings, J. L. A., Guedj, F., Bianchi, D. W., & Haydar, T. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2513-15.2016 · Cited by 65
Murine models for Down syndrome
Dierssen, M., Fillat, C., Crnic, L. S., Arbonés, M. L., Flórez, J., & Estivill, X. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00523-6 · Cited by 68
GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome
Martín, J. Z. D. S., Delabar, J. M., Bacci, A., & Potier, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.002 · Cited by 70
Trisomy 21 and Down syndrome: a short review
Sommer, C., & Henrique‐Silva, F. (2008) · Brazilian Journal of Biology · doi:10.1590/s1519-69842008000200031 · Cited by 59
Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300066 · Cited by 59
Hernandez, D., Mee, P. J., Martin, J. E., Tybulewicz, V. L. J., & Fisher, E. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.923 · Cited by 56
Gene Network Disruptions and Neurogenesis Defects in the Adult Ts1Cje Mouse Model of Down Syndrome
Hewitt, C., Ling, K., Merson, T. D., Simpson, K., Ritchie, M. E., King, S. L., Pritchard, M. A., Smyth, G. K., Thomas, T., Scott, H. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011561 · Cited by 57
Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801
Siddiqui, A. H., Lacroix, T., Stasko, M. R., Scott-McKean, J. J., Costa, A. C. S., & Gardiner, K. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00428.x · Cited by 64
Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cellsPreprint
Kurabayashi, N., & Sanada, K. (2013) · Genes & Development · doi:10.1101/gad.226381.113 · Cited by 57
Hematopoietic defects in the Ts1Cje mouse model of Down syndrome
Carmichael, C., Majewski, I. J., Alexander, W. S., Metcalf, D., Hilton, D. J., Hewitt, C., & Scott, H. S. (2008) · Blood · doi:10.1182/blood-2008-06-161422 · Cited by 56
Cre/loxP-Mediated Chromosome Engineering of the Mouse Genome
Brault, V., Besson, V., Magnol, L., Duchon, A., & Hérault, Y. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-35109-2_2 · Cited by 56
Mouse Models for Down Syndrome-Associated Developmental Cognitive Disabilities
Liu, C., Belichenko, P. V., Zhang, L., Fu, D., Kleschevnikov, A. M., Baldini, A., Antonarakis, S. E., Mobley, W. C., & Yu, Y. E. (2011) · Developmental Neuroscience · doi:10.1159/000329422 · Cited by 57
Self-citationPotier, M., Rivals, I., MERCIER, G., Ettwiller, L. M., Moldrich, R. X., Laffaire, J., Personnaz, L., Rossier, J., & Dauphinot, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03624.x · Cited by 60
Gene-dosage effects in Down syndrome and trisomic mouse models.
Gardiner, K. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-244 · Cited by 55
Cramer, N., & Galdzicki, Z. (2012) · Neural Plasticity · doi:10.1155/2012/101542 · Cited by 60
Mou, X., Wu, Y., Cao, H., Meng, Q., Wang, Q., Sun, C., Hu, S., Ma, Y., & Zhang, H. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt105 · Cited by 54
Davisson, M. T., & Costa, A. C. S. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4887-4_13 · Cited by 55
Characterization of the cardiac phenotype in neonatal Ts65Dn mice
Williams, A. D., Mjaatvedt, C. H., & Moore, C. S. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21416 · Cited by 57
Down syndrome and mouse models
Kola, I., & Hertzog, P. J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80088-9 · Cited by 53
Behavioral and Genetic Evidence for GIRK Channels in the CNS
Mayfield, J., Blednov, Y. A., & Harris, R. A. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.016 · Cited by 54
Driscoll, L. L., Carroll, J. C., Moon, J., Crnic, L. S., Levitsky, D. A., & Strupp, B. J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.6.1196 · Cited by 53
Comparative Genomic Sequence Analysis of the Human Chromosome 21 Down Syndrome Critical RegionPreprint
豊田, 敦., Noguchi, H., 野口, 英., Ito, T., Pletcher, M. T., Sakaki, Y., Reeves, R. H., & Hattori, M. (2002) · Genome Research · doi:10.1101/gr.153702 · Cited by 52
Animal models of mental retardation: from gene to cognitive function
Branchi, I., Bichler, Z., Berger-Sweeney, J. E., & Ricceri, L. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00016-2 · Cited by 52
Starbuck, J. M., Dutka, T., Ratliff, T. S., Reeves, R. H., & Richtsmeier, J. T. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36594 · Cited by 50
GABAB–GIRK2-Mediated Signaling in Down Syndrome
Cramer, N., Best, T. K., Stoffel, M., Siarey, R. J., & Galdzicki, Z. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)58015-3 · Cited by 49
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
Chen, Y., Dyakin, V. V., Branch, C. A., Ardekani, B. A., Yang, D., Guilfoyle, D. N., Peterson, J. N., Peterhoff, C. M., Ginsberg, S. D., Cataldo, A. M., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.026 · Cited by 50
Mouse autosomal trisomy: two’s company, three’s a crowd
Hernandez, D., & Fisher, E. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01743-6 · Cited by 49
Kleschevnikov, A. M., Yu, J., Kim, J., Lysenko, L. V., Zeng, Z., Yu, Y. E., & Mobley, W. C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.009 · Cited by 49
Self-citationDevelopmental Defects in Trisomy 21 and Mouse Models
Delabar, J. M., Aflalo-Rattenbac, R., & Créau, N. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.322 · Cited by 47
The power of comparative and developmental studies for mouse models of Down syndrome
Moore, C. S., & Roper, R. J. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9030-8 · Cited by 47
Neuronal cell death in Down’s syndrome
Sawa, A. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_6 · Cited by 47
Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00117 · Cited by 45
Rachidi, M., Lopes, C., Charron, G., Delezoide, A., Paly, E., Bloch, B., & Delabar, J. M. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.05.004 · Cited by 47
Harris‐Cerruti, C., Kamsler, A., Kaplan, B., Lamb, B. T., Segal, M., & Groner, Y. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03188.x · Cited by 47
Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome
Torres, M. D., Garcı́a, O., Tang, C. G., & Busciglio, J. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.09.025 · Cited by 49
Sleep and EEG features in genetic models of Down syndrome
Colas, D., Valletta, J. S., Takimoto‐Kimura, R., Nishino, S., Fujiki, N., Mobley, W. C., & Mignot, E. J.-M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.014 · Cited by 46
Self-citationAnalysis of motor dysfunction in down Syndrome reveals motor neuron degeneration.
Watson-Scales, S., Kalmar, B., Lana-Elola, E., Gibbins, D., La Russa, F., Wiseman, F., Williamson, M., Saccon, R., Slender, A., Olerinyova, A., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007383 · Cited by 45
Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.703876 · Cited by 47
Costa, A. C. S. (2011) · Developmental Neuroscience · doi:10.1159/000330861 · Cited by 44
Segmental trisomy of chromosome 17: A mouse model of human aneuploidy syndromes
Vacı́k, T., Ort, M., Gregorová, S., Strnad, P., Blatný, R., Conte, N., Bradley, A., Bureš, J., & Forejt, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500802102 · Cited by 44
Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome
Andrade‐Talavera, Y., Benito, I., Casañas, J. J., Moreno, A. R., & Montesinos, M. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.005 · Cited by 42
Mouse Chromosome Engineering for Modeling Human Disease
van der Weyden, L., & Bradley, A. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115741 · Cited by 42
Dissecting Alzheimer disease in Down syndrome using mouse models
Choong, X. Y., Tosh, J., Pulford, L. J., & Fisher, E. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00268 · Cited by 41
Mouton‐Liger, F., Thomas, S., Rattenbach, R., Magnol, L., Larigaldie, V., Ledru, A., Hérault, Y., Verney, C., & Créau, N. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22651 · Cited by 41
New technique using galactose‐specific lectin for isolation of fetal cells from maternal blood
Kitagawa, M., Sugiura, K., Omi, H., Akiyama, Y., 金山, 清., Shinya, M., Tanaka, T., Yura, H., & Sago, H. (2002) · Prenatal Diagnosis · doi:10.1002/pd.222 · Cited by 40
Self-citationRachidi, M., & Lopes, C. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.2.83 · Cited by 40
Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression
Duclot, F., Lapierre, M., Fritsch, S., White, R., Parker, M. G., Maurice, T., & Cavaillès, V. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00731.x · Cited by 41
Kir Channel Molecular Physiology, Pharmacology, and Therapeutic Implications
Cui, M., Cantwell, L., Zorn, A., & Logothetis, D. E. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_501 · Cited by 44
Differential gene expression studies to explore the molecular pathophysiology of Down syndrome
Antonarakis, S. E., Lyle, R., Chrast, R., & Scott, H. S. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00103-5 · Cited by 41
Modeling Down syndrome in animals from the early stage to the 4.0 models and next
Moreno, M. D. M. M., Brault, V., Birling, M., Pavlovic, G., & Hérault, Y. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2019.08.001 · Cited by 35
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome
Contestabile, A., Fila, T., Cappellini, A., Bartesaghi, R., & Ciani, E. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00587.x · Cited by 39
Genes and sex hormones interaction in neurodevelopmental disorders
Romano, E., Cosentino, L., Laviola, G., & Filippis, B. D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.019 · Cited by 42
Kahlem, P. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9053-z · Cited by 36
Distinct Defects in Spine Formation or Pruning in Two Gene Duplication Mouse Models of Autism
Wang, M., Li, H., Takumi, T., Qiu, Z., Xu, X., Yu, X., & Bian, W.-J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0111-8 · Cited by 36
Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction.
Raveau, M., Nakahari, T., Asada, S., Ishihara, K., Amano, K., Shimohata, A., Sago, H., & Yamakawa, K. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx007 · Cited by 35
Self-citationChabert, C., Jamon, M., Cherfouh, A., Duquenne, V., Smith, D., Rubin, E. M., & Roubertoux, P. L. (2004) · Behavior Genetics · doi:10.1007/s10519-004-5584-3 · Cited by 35
Self-citationThe in vivo Down syndrome genomic library in mouse
Hérault, Y., Duchon, A., Velot, É., Maréchal, D., & Brault, V. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00009-1 · Cited by 36
Aging and intellectual disability: Insights from mouse models of down syndrome
Ruparelia, A., Pearn, M. L., & Mobley, W. C. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1127 · Cited by 37
Self-citationDYRK1A regulates Hap1–Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome
Xiang, J., Yang, S., Xin, N., Gaertig, M. A., Reeves, R. H., Li, S., & Li, X.-J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614893114 · Cited by 35
Chromosome 21: from sequence to applications
Antonarakis, S. E. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00185-4 · Cited by 33
Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice
Raveau, M., Polygalov, D., Boehringer, R., Amano, K., Yamakawa, K., & McHugh, T. J. (2018) · eLife · doi:10.7554/elife.31543 · Cited by 32
Chi, C., Knight, W. E., Riching, A. S., Zhang, Z., Tatavosian, R., Zhuang, Y., Moldovan, R., Rachubinski, A. L., Gao, D., Xu, H., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107012 · Cited by 30
Dysregulated systemic metabolism in a Down syndrome mouse model
Sarver, D. C., Xu, C., Vélez, L. M., Aja, S. M., Jaffe, A. E., Seldin, M. M., Reeves, R. H., & Wong, G. W. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101666 · Cited by 32
Mouse-based genetic modeling and analysis of Down syndrome
Xing, Z., Li, Y., Pao, A., Bennett, A. S., Tycko, B., Mobley, W. C., & Yu, Y. E. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw040 · Cited by 32
Self-citationCréau, N. (2012) · Neural Plasticity · doi:10.1155/2012/171639 · Cited by 30
Human and mouse model cognitive phenotypes in Down syndrome
Edgin, J. O., Mason, G. M., Spanò, G., Fernández, A., & Nadel, L. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00007-8 · Cited by 36
Direct modulation of G protein-gated inwardly rectifying potassium (GIRK) channels
Nguyen, H., Glaaser, I. W., & Slesinger, P. A. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1386645 · Cited by 29
The Critical Region in Trisomy 21
Nelson, D. L., & Gibbs, R. A. (2004) · Science · doi:10.1126/science.1105226 · Cited by 31
Autonomous trisomic rescue of Down syndrome cells
Inoue, M., Kajiwara, K., Yamaguchi, A., Kiyono, T., Samura, O., Akutsu, H., Sago, H., Okamoto, A., & Umezawa, A. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0230-0 · Cited by 30
Self-citationMouse models of cognitive disabilities in trisomy 21 (Down syndrome)
Roubertoux, P. L., & Carlier, M. (2010) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30280 · Cited by 28
Kawakubo, T., Mori, R., Shirotani, K., Iwata, N., & Asai, M. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00825 · Cited by 29
Cholinergic neurodegeneration in Alzheimer disease mouse models
Shekari, A., & Fahnestock, M. L. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00013-7 · Cited by 30
Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome
Fernandez, F., & Garner, C. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.075 · Cited by 28
Bala, U., Leong, M. P.-Y., Lim, C. L., Shahar, H. K., Othman, F., Lai, M. I., Law, Z. K., Ramli, K., Htwe, O., Ling, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197711 · Cited by 29
Brain Phenotype of Transgenic Mice Overexpressing Cystathionine β-Synthase
Régnier, V., Billard, J., Gupta, S., Potier, B., Woerner, S., Paly, E., Ledru, A., David, S., Luilier, S., Bizot, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029056 · Cited by 30
Clinical trials in children with Down syndrome: Issues from a cognitive research perspective
Heller, J. H., Spiridigliozzi, G. A., Crissman, B. G., Sullivan‐Saarela, J. A., Li, J. S., & Kishnani, P. S. (2006) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30103 · Cited by 27
Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease
Levine, S., Saltzman, A., Levy, E., & Ginsberg, S. D. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.10.006 · Cited by 28
Apoptosis in Down’s syndrome: lessons from studies of human and mouse models
Rueda, N., Flórez, J., & Martínez‐Cué, C. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0785-3 · Cited by 31
A year of unprecedented progress in Down syndrome basic research
Reeves, R. H., & Garner, C. C. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20165 · Cited by 27
Human neural stem cells: a new tool for studying cortical development in Down's syndrome
Bhattacharyya, A., & Svendsen, C. N. (2003) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2003.00025.x · Cited by 27
Roubertoux, P. L., Baril, N., Cau, P., Scajola, C., Ghata, A. S., Bartoli, C., Bourgeois, P., di Christofaro, J., Tordjman, S., & Carlier, M. (2017) · Behavior Genetics · doi:10.1007/s10519-017-9835-5 · Cited by 27
Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome
Das, D., Phillips, C., Hsieh, W., Sumanth, K., Dang, V., & Salehi, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.004 · Cited by 27
Neuronal dysfunction in Down syndrome: Contribution of neuronal models in cell culture
Saud, K., Arriagada, C., Cárdenas, A. M., Shimahara, T., Allen, D. D., Caviedes, R., & Caviedes, P. A. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.013 · Cited by 26
Wiltshire, T., Pletcher, M. T., Cole, S. E., Villanueva, M. P., Birren, B. W., Lehoczky, J. A., Dewar, K., & Reeves, R. H. (1999) · Genome Research · doi:10.1101/gr.9.12.1214 · Cited by 25
Brain circuit pathology in Down syndrome: from neurons to neural networks
Bartesaghi, R. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0067 · Cited by 25
Alterations of brain circuits in Down syndrome murine models
Gotti, S., Caricati, E., & Panzica, G. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.09.002 · Cited by 25
Mojabi, F. S., Fahimi, A., Moghadam, S., Moghadam, S., McNerney, M. W., Ponnusamy, R., Kleschevnikov, A. M., Mobley, W. C., & Salehi, A. (2016) · Hippocampus · doi:10.1002/hipo.22664 · Cited by 24
Self-citation
Metadata
- Authors
- Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., Epstein, C. J., & Huang, T.-T.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Huang, Ting-Ting
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-05-26
- Volume
- 95
- Issue
- 11
- Pages
- 6256-6261
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC27649
- OpenAlex
- W2079155607
- Cited by
- 382
- References
- 32
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 10 · 2021: 14 · 2020: 9 · 2019: 12 · 2018: 11 · 2017: 20 · 2016: 13 · 2015: 8 · 2014: 14 · 2013: 14 · 2012: 23
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl018574-26, 5r01hd031498-05)
- National Institute on Aging (AG-08938, P01AG008938)
- National Heart, Lung, and Blood Institute (HL-18574)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-31498)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Down syndrome, mouse model, learning deficits, Morris water maze, locomotor activity, hippocampal dysfunction, basal forebrain cholinergic neurons, SOD1, MX1, chromosome 21q22
- MeSH terms
- Animals, Behavior, Animal, Disease Models, Animal, Down Syndrome, Humans, Learning Disabilities, Trisomy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review